Arrhythmia & Electrophysiology Round Table Discussion

Roundtable Discussion

SESSION 4: Atrial Fibrillation: Rate versus Rhythm


Angelo Auricchio, Fondazione Cardiocentro Ticino, Lugano, CH
Hein Heidbuchel, University Hospital Gasthuisberg, Leuven, BE
Gerhard Hindricks, Heart Center Leipzig, DE
Josef Kautzner, Institute for Clinical and Experimental Medicine, Prague, CZ
Pier Lambiase, Heart Hospital, University College London, UK
Mark O'Neill, St Thomas’ Hospital and King’s College London, UK
Richard Schilling, St Bartholomew’s and The Royal London Hospital, UK

In this 4th video, the Round Table asks the question, ‘Does catheter ablation improve prognosis or is safer than drugs for treatment for rhythm control in atrial fibrillation?’

The Round Table discusses treatment approaches available to the arrhythmologists to achieve the best patient outcomes in atrial fibrillation, with insightful opinions expressed on both the role of catheter ablation and various drug options.

The assigned learning objectives for this roundtable are:
  • Increase physician awareness on heart rhythm disorders
  • Encourage development of the referral pathway between cardiologists and EPs
  • Discuss novel and emerging technologies being utilised in the EP lab
  • Debate risk stratification criteria for heart rhythm disorders
  • Assess risk stratification for CRT non-responders
  • Consider radiation dose reduction strategies for EPs

This round table discussion is intended for an international audience, specifically electrophysiologists, cardiologists and allied healthcare professionals seeking to improve their knowledge of heart rhythm disorders.

The Arrhythmia & Electrophysiology Round Table event and videos were supported by an unrestricted grant from Biosense Webster. The view and opinions expressed are those of the attendees, and not necessarily of Biosense Webster.